|
largestdrugmaker by revenue, was sued by investors in OrielTherapeutics over claims one of its units defrauded them as partof an acquisition of the U.S. maker of respiratory drugs.Officials of Novartis’s Sandoz AG’s generic-drug businessmade “fraudulent misrepresentations” in connection with the2010 purchase of Durham, North Carolina-based Oriel and thosestatements prompted Oriel investors to sell...
|
